Matthew Callahan

Matthew Callahan

Founder bei BOTANIX PHARMACEUTICALS LIMITED

Vermögen: 1 Mio $ am 31.03.2024

51 Jahre
Health Technology
Finance
Commercial Services

Profil

Matthew Callahan is the founder of iCeutica, Inc. (founded in 2005) and Stone Ridge Ventures Pty Ltd.
(founded in 2005).
He is currently the Chief Executive Officer at Churchill Pharmaceuticals and a Director at Riverside Partners LLC (New York) since 2021.
He is also a Non-Executive Director at Intellection Pty Ltd., a Director at Ben Franklin Technology Partners of Southeastern Pennsylvania since 2016, an Executive Director at Botanix Pharmaceuticals, Inc., a Non-Executive Director at Nemgenix Pty Ltd., a Non-Executive Director at Matteo Mining Corp.
Pty Ltd., a Director at Glycan Bioscience LLC, a Director at Thylacine Consulting LLC, an Executive Director at Respirion Pharmaceuticals Pty Ltd., and a Director at Microsize, Inc. Mr. Callahan's former positions include being the Chief Executive Officer at Dimerix Bioscience Pty Ltd.
from 2003 to 2005, a Director at The Cash Store Australia Holdings, Inc. in 2009, a Director at Glycan Biosciences, Inc. from 2006 to 2011, a Non-Executive Director at Orthocell Ltd.
from 2006 to 2019, a Non-Executive Director at Orthocell Ltd.
from 2020 to 2023, a Non-Executive Director at Emyria Ltd.
from 2018 to 2023, a General Manager at Xelor Software, Inc., and a General Manager & General Counsel at Nearmap Pty Ltd.
Mr. Callahan's education includes an undergraduate degree and an MBA from The University of Western Australia.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
05.10.2023 19 655 556 ( 5,36% ) 756 542 $ 31.03.2024
15.01.2024 1 229 622 ( 0,59% ) 312 865 $ 31.03.2024

Aktive Positionen von Matthew Callahan

UnternehmenPositionBeginn
BOTANIX PHARMACEUTICALS LIMITED Founder 10.02.2020
Director/Board Member -
Founder 01.01.2005
Private Equity Investor 01.09.2021
Director/Board Member -
Thylacine Consulting LLC Director/Board Member -
Churchill Pharmaceuticals Chief Executive Officer -
Director/Board Member -
Director/Board Member -
░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Alle aktiven Positionen von Matthew Callahan

Ehemalige bekannte Positionen von Matthew Callahan

UnternehmenPositionEnde
░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Matthew Callahan im Detail an

Ausbildung von Matthew Callahan

The University of Western Australia Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Matthew Callahan im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

22

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
BOTANIX PHARMACEUTICALS LIMITED

Health Technology

ORTHOCELL LIMITED

Health Technology

EMYRIA LIMITED

Technology Services

Private Unternehmen18

Health Technology

Technology Services

Industrial Services

Finance

Non-Energy Minerals

Miscellaneous

Finance

Finance

Glycan Biosciences, Inc.

Distribution Services

Health Technology

Commercial Services

Non-Energy Minerals

Health Technology

Churchill Pharmaceuticals

Thylacine Consulting LLC

Commercial Services

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Matthew Callahan